CAS: 14984-68-0; 1-(2-((4-Chlorophenyl)(Phenyl)Methoxy)Ethyl)Piperidine Hydrochloride

该化合物是一种主要用作抗素或咳嗽抑制剂的药物化合物,被归类为非类尿咳抑制剂,并经常用于治疗与各种呼吸系统条件有关的干咳;该物质在大脑中展示了一种双重行动机制,其核心功能是抑制咳嗽反应,其边缘功能是减少气道刺激;氯丙烯酸盐通常以口服药片或糖浆的形式施用;其化学结构包括管状环,有助于其药性.该化合物一般都得到良好的缓解,但与所有药物一样,可能具有副作用,包括沉睡或胃肠紊乱.必须指出,不建议用于某一年龄的儿童使用氯丙烯,其使用应当由保健专业人员指导,以确保安全和功效.与任何药物一样,坚持施用准则和了解与其他药物的潜在相互作用对于最佳治疗结果至关重要.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

1-piperidinoethanol 1-chloro-4-(chloro(phenyl)methyl)benzene 2-(piperidin-4-yl)ethyl chloride (4-chlorophenyl)phenylmethanol

合成工艺路线路线简述

    N-羟乙基哌啶,4-氯二苯氯甲烷置于三乙胺,盐酸体系中,用 二氯甲烷,醋酸异丙酯 用作溶剂,化学反应 4.0H,以91.2%的收率获得咳平 盐酸盐
    参考文献:一种盐酸氯哌丁的制备方法
    标题:一种盐酸氯哌丁的制备方法
    摘要:一种盐酸氯哌丁的制备方法,将式(ⅵ)和式(ⅲ)置于溶剂或无溶剂,经过缩合或醚化反应,分离得到1‑[2‑[(4‑氯‑α苯基苄基)氧]乙基]哌啶(ⅱ);1‑[2‑[(4‑氯‑α苯基苄基)氧]乙基]哌啶在溶剂中与氯化氢或盐酸成盐得到盐酸氯哌丁.本发明工艺条件温和,操作方便,简单,适用于大规模工业化生产,生产得到的目标产品纯度达到99.7%以上,且单个杂质小于0.1%.

    海关参考信息

    专利信息


    专利号:US-9708317-B2
    优先权日:2013-11-25
    标 题 :Process for the preparation of 8-(4-aminophenoxy)-4H-pyrido[2,3-B]pyrazin-3-one derivatives
    发明人:ZAMBON ALFONSO; NICULESCU-DUVAZ DAN; CHUBB RICHARD; SPRINGER CAROLINE JOY
    权利人:CANCER RES TECH LTD; INST OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE); OXY SCIENT LTD; THE INST OF CANCER RESEARCH: ROYAL CANCER HOSPITAL
    摘要:The present invention pertains generally to the field of organic chemical synthesis, and in particular to certain methods for the synthesis of 8-(4-aminophenyoxy)-4H-pyrido[2,3-b]pyrazin-3-one and related compounds (denoted herein as (3)) from 4-(4-aminophenyoxy)pyridine-2,3-diamine and related compounds (denoted herein as (1)), by reaction with glyoxylic acid (denoted herein as (2)). The compounds (3) are useful in the synthesis of known anti-cancer agents, such as 1-(5-tert-butyl-2-(4-methyl-phenyl)-pyrazol-3-yl)-3-[2-fluoro-4-[(3-oxo-4H-pyrido[2,3-b]pyrazin-8-yl)oxy]phenyl]urea.

    专利号:US-8835477-B2
    优先权日:2009-10-06
    标题 :Method for the synthesis of 2-thiohistidine and the like
    发明人:ERDELMEIER IRÈNE; DAUNAY SYLVAIN
    权利人:ERDELMEIER IRÈNE; DAUNAY SYLVAIN; TETRAHEDRON
    摘要:Methods for the synthesis of 2-thiohistidine or a derivative thereof of the formula (I), or of a physiologically acceptable salt, a tautomer, a stereoisomer or a mixture of stereoisomers in any proportions thereof, from a compound of the formula (II) or a physiologically acceptable salt, a tautomer, a stereoisomer or a mixture of stereoisomers in any proportions thereof, by cleavage reaction in the presence of a thiol at a temperature higher than or equal to 60° C. The invention also relates to compounds of the formula (II) and a method for the synthesis thereof.

    专利号:WO-2023044581-A1
    优先权日:2021-09-24
    标题 :Flow synthesis of porous collagen microparticles for versatile tissue engineering applications
    发明人:SINGH SUSHANT; SAMIEI EHSAN; GUENTHER AXEL; VERES TEODOR
    权利人:GOVERNING COUNCIL UNIV TORONTO; NAT RES COUNCIL CANADA; SINGH SUSHANT
    摘要:A microfluidic flow synthesis method for collagen-based microparticles. Macro-porous fibrillar microparticles of pure collagen and composite collagen-GAG were formed, where the particle size and porosity were controlled by the flow synthesis parameters such as precursor flow rates. Using human dermal fibroblasts (hDFB) and umbilical cord derives mesenchymal stem cells (ucMSC), the capacity of the presented collagen and collagen-GAG microparticles to serve as cell culture substrates has been shown, to enable casting of tissues, forming spheroids, and as shear-thinning bioinks for bioprinting. At high packing densities, jammed collagen-based microparticles along with cells constitute a shear-thinning bioink for extrusion bioprinting applications. Bioprinted constructs exhibit a high porosity matrix due to the space between the microparticles, facilitating macromolecular transport, and cell proliferation and migration.

    专利号:US-6013796-A
    优先权日:1996-07-26
    标 题:Preparation of naltrexone from codeine and 3-benzylmorphine
    发明人:HUANG BAO-SHAN; LU YANSONG; JI BEN-YI; CHRISTODOULOU ARIS P
    权利人:PENICK CORP
    摘要:For the synthesis of 3-methylnaltrexone from codeine in this invention, codeine is converted to 6-acetylcodeine, which is N-demethylated to 6-acetylcodeine hydrochloride, followed by alkylating the nitrogen to form 17-cyclopropylmethylnorcodeine. The latter is oxidized to 17-cyclopropylmethylnorcodeinone. For the synthesis of naltrexone from morphine in this invention, morphine is converted to 3-benzylnormorphine as described above in the synthesis of noroxymorphone. 3-Benzylnormorphine is reacted with cyclopropylmethyl halide to produce 3-benzyl-17cyclopropylmethylnormorphine, a novel compound, which is oxidized to 3-benzyl-17-cyclopropylmethyl-normorphinone, a novel compound, by Swern oxidation.

    专利号:US-6136452-A
    优先权日:1998-02-27
    标 题:Centrifugal synthesis and processing of functionally graded materials
    发明人:MUNIR ZUHAIR A; LAI WEI NONG; RISBUD SUBHASH H; MCCOY BENJAMIN J
    权利人:UNIV CALIFORNIA
    摘要:A method through which we can synthesize Functionally Graded Materials (FGM). Such materials are made so that their composition changes gradually from one point to another, such as in the example of gradient index (GRIN) optical components. A novel aspect of our method is the imposition of a centrifugal force during the combustion synthesis of composite materials for structural, optical, or electronic applications, with the result that the composition and the particle size of the metallic (or ceramic) component changes continuously and across the thickness of the product. We have prepared such FGM as ZrO 2 +Ni, ZrO 2 +Cu and Al 2 O 3 +Cu.

    专利号:US-10640508-B2
    优先权日:2017-10-13
    标 题 :Diazene directed modular synthesis of compounds with quaternary carbon centers
    发明人:MOVASSAGHI MOHAMMAD; LINDOVSKA PETRA
    权利人:MASSACHUSETTS INST TECHNOLOGY
    摘要:Diazene-directed modular synthesis is described for the preparation Csp2-Csp3 and Csp3-Csp3 linkages where one or more stereogenic quaternary carbon centers are formed. The disclosed methods are directed to the preparation of compounds of Formula (I), or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, from compounds of Formula (II): n nwherein R 1 -R 5 and q are as defined independently for each occurrence herein. A wide variety of compounds can be accessed in this manner, including oligocyclotryptamines, where the stereochemistry of each subunit is beneficially secured before fragment coupling.
    莱芜市润中精细化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.runzhongchem.com
    电话: 0536-7868377👤
    📞莱芜市润中精细化工有限公司 ⚠️参考联系方式

    销售电话:0536-7868377
    邮箱:sq@runzhongchem.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    重庆康乐制药有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.cqkl.com.cn
    企业联系电话:023-68980207👤
    📞重庆康乐制药有限公司 ⚠️参考联系方式
    联系人:李伟
    电话:023-68980207


    邮箱:cqkl@cqkl.com.cn
    通信地址: 重庆(长寿)化工园区,化中大道4号
    邮编: 400061
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:重庆(长寿)化工园区,化中大道4号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Bollettino Chimico Farmaceutico., 122(384), 1983 []
    摘要:Gekkan Yakuji. Pharmaceuticals Monthly., 7(1496), 1965
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知